Trials / Recruiting
RecruitingNCT04634916
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
A Prospective, Multi-Center Clinical Study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 280 (estimated)
- Sponsor
- C. R. Bard · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EndoAVF Creation | Subjects will have an endoAVF created using the WavelinQ EndoAVF System |
Timeline
- Start date
- 2021-03-26
- Primary completion
- 2027-06-01
- Completion
- 2027-09-01
- First posted
- 2020-11-18
- Last updated
- 2026-03-27
Locations
17 sites across 2 countries: United States, Australia
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04634916. Inclusion in this directory is not an endorsement.